ADMA BIOLOGICS, INC. Quarterly Debt-to-equity in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Adma Biologics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q3 2024.
  • Adma Biologics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 104 %, a 21% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 104 -27.7 -21% Sep 30, 2024
Q2 2024 124 -21.1 -14.6% Jun 30, 2024
Q1 2024 134 -17.4 -11.5% Mar 31, 2024
Q4 2023 135 -18.8 -12.2% Dec 31, 2023
Q3 2023 132 -12.9 -8.92% Sep 30, 2023
Q2 2023 145 +13.9 +10.6% Jun 30, 2023
Q1 2023 151 +32.3 +27.2% Mar 31, 2023
Q4 2022 154 +43.9 +39.9% Dec 31, 2022
Q3 2022 145 +24.4 +20.2% Sep 30, 2022
Q2 2022 131 +5.04 +4.01% Jun 30, 2022
Q1 2022 119 -17.5 -12.9% Mar 31, 2022
Q4 2021 110 -30.2 -21.5% Dec 31, 2021
Q3 2021 120 -45.2 -27.3% Sep 30, 2021
Q2 2021 126 -57.5 -31.4% Jun 30, 2021
Q1 2021 136 -64.6 -32.2% Mar 31, 2021
Q4 2020 140 -167 -54.4% Dec 31, 2020
Q3 2020 166 -132 -44.3% Sep 30, 2020
Q2 2020 183 -82.5 -31.1% Jun 30, 2020
Q1 2020 201 -28.3 -12.3% Mar 31, 2020
Q4 2019 308 +101 +48.9% Dec 31, 2019
Q3 2019 297 +119 +67% Sep 30, 2019
Q2 2019 266 +61.5 +30.1% Jun 30, 2019
Q1 2019 229 -13.5 -5.57% Mar 31, 2019
Q4 2018 207 -96.3 -31.8% Dec 31, 2018
Q3 2018 178 -503 -73.9% Sep 30, 2018
Q2 2018 204 -942 -82.2% Jun 30, 2018
Q1 2018 243 +1.22K Mar 31, 2018
Q4 2017 303 +2.93K Dec 31, 2017
Q3 2017 681 -7.66K -91.8% Sep 30, 2017
Q2 2017 1.15K -393 -25.5% Jun 30, 2017
Q1 2017 -978 -1.73K -230% Mar 31, 2017
Q4 2016 -2.63K -2.93K -970% Dec 31, 2016
Q3 2016 8.34K +8.09K +3236% Sep 30, 2016
Q2 2016 1.54K +1.34K +655% Jun 30, 2016
Q1 2016 750 +572 +320% Mar 31, 2016
Q4 2015 302 +144 +91% Dec 31, 2015
Q3 2015 250 +152 +154% Sep 30, 2015
Q2 2015 204 +98.8 +94.1% Jun 30, 2015
Q1 2015 178 +61.8 +53% Mar 31, 2015
Q4 2014 158 +33 +26.4% Dec 31, 2014
Q3 2014 98.4 -91.6 -48.2% Sep 30, 2014
Q2 2014 105 +22.2 +26.8% Jun 30, 2014
Q1 2014 117 +77.6 +199% Mar 31, 2014
Q4 2013 125 +105 +528% Dec 31, 2013
Q3 2013 190 +174 +1112% Sep 30, 2013
Q2 2013 82.8 Jun 30, 2013
Q1 2013 39 Mar 31, 2013
Q4 2012 19.9 Dec 31, 2012
Q3 2012 15.7 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.